|
C13ORF37 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.824400E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.742200E-01 |
| Normal-vs-Stage2 |
6.746000E-01 |
| Normal-vs-Stage3 |
4.210800E-01 |
| Normal-vs-Stage4 |
5.248500E-02 |
| Stage1-vs-Stage2 |
6.381200E-01 |
| Stage1-vs-Stage3 |
4.982100E-02 |
| Stage1-vs-Stage4 |
1.378190E-02 |
| Stage2-vs-Stage3 |
3.228400E-01 |
| Stage2-vs-Stage4 |
6.784300E-02 |
| Stage3-vs-Stage4 |
3.501400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.288400E-01 |
| Normal-vs-AfricanAmerican |
5.220400E-01 |
| Normal-vs-Asian |
6.897800E-01 |
| Caucasian-vs-AfricanAmerican |
7.947200E-01 |
| Caucasian-vs-Asian |
5.855600E-01 |
| AfricanAmerican-vs-Asian |
5.212200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.668000E-01 |
| Normal-vs-Female |
4.290400E-01 |
| Male-vs-Female |
4.078100E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.706400E-01 |
| Normal-vs-Extreme_Weight |
3.175600E-01 |
| Normal-vs-Obese |
9.169800E-01 |
| Normal-vs-Extreme_Obese |
3.895200E-01 |
| Normal_Weight-vs-Extreme_Weight |
3.975400E-01 |
| Normal_Weight-vs-Obese |
7.694000E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.684200E-01 |
| Extreme_Weight-vs-Obese |
1.799600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.868200E-01 |
| Obese-vs-Extreme_Obese |
4.061800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.498400E-01 |
| Normal-vs-Age(41-60Yrs) |
9.904600E-01 |
| Normal-vs-Age(61-80Yrs) |
4.331400E-01 |
| Normal-vs-Age(81-100Yrs) |
1.733020E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.623200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.664800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.379200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.152800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.188200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.158000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.525800E-01 |
| Normal-VS-Type2 PRCC |
2.440800E-01 |
| Normal-VS-KIRP CIMP |
3.600600E-01 |
| Normal-VS-Unclassified PRCC |
4.529800E-01 |
| Type1 PRCC-VS-Type2 PRCC |
3.438800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.674200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
7.463600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.151030E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
6.860000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.712990E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.729180E-01 |
| Normal-vs-N1 |
1.276770E-01 |
| Normal-vs-N2 |
5.114000E-01 |
| N0-vs-N1 |
1.677970E-02 |
| N0-vs-N2 |
9.219000E-01 |
| N1-vs-N2 |
2.660000E-01 |
|
|
